Total Payments
$10,483
2024 Payments
$1,071
Companies
41
Transactions
408
Medicare Patients
7,610
Medicare Billing
$537,389
Payment Breakdown by Category
Food & Beverage$10,097 (96.3%)
Education$386.67 (3.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,097 | 402 | 96.3% |
| Education | $386.67 | 6 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,738 | 102 | $0 (2024) |
| Janssen Biotech, Inc. | $859.87 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $729.88 | 31 | $0 (2024) |
| PFIZER INC. | $723.05 | 42 | $0 (2023) |
| GENZYME CORPORATION | $669.30 | 9 | $0 (2023) |
| Organogenesis Inc. | $426.81 | 1 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $406.48 | 20 | $0 (2024) |
| Lilly USA, LLC | $377.53 | 23 | $0 (2024) |
| Galderma Laboratories, L.P. | $377.48 | 15 | $0 (2024) |
| Incyte Corporation | $376.53 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,071 | 49 | ABBVIE INC. ($332.19) |
| 2023 | $2,314 | 74 | ABBVIE INC. ($457.24) |
| 2022 | $1,088 | 26 | ABBVIE INC. ($336.94) |
| 2021 | $400.49 | 18 | Incyte Corporation ($147.89) |
| 2020 | $201.28 | 9 | AbbVie Inc. ($126.53) |
| 2019 | $1,473 | 78 | AbbVie, Inc. ($398.03) |
| 2018 | $2,041 | 84 | AbbVie, Inc. ($652.81) |
| 2017 | $1,896 | 70 | AbbVie, Inc. ($317.53) |
All Payment Transactions
408 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.96 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.99 | General |
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $127.23 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.95 | General |
| Category: Dermatology | ||||||
| 10/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Dermatology | ||||||
| 09/05/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Immunology | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Dermatology | ||||||
| 08/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: DERMATOLOGY | ||||||
| 08/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: Immunology | ||||||
| 07/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Dermatology | ||||||
| 07/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Dermatology | ||||||
| 07/08/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: ACNE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,026 | 4,138 | $341,732 | $150,166 |
| 2022 | 14 | 1,740 | 3,467 | $285,075 | $123,957 |
| 2021 | 15 | 1,897 | 3,664 | $295,528 | $129,262 |
| 2020 | 14 | 1,947 | 3,717 | $318,911 | $134,003 |
Total Patients
7,610
Total Services
14,986
Medicare Billing
$537,389
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 387 | 529 | $60,847 | $30,347 | 49.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 228 | 300 | $42,012 | $21,949 | 52.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 176 | 233 | $36,810 | $19,243 | 52.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 94 | 160 | $51,480 | $18,015 | 35.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 364 | 495 | $45,480 | $16,386 | 36.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 219 | 274 | $35,041 | $16,354 | 46.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 286 | 1,814 | $30,044 | $8,185 | 27.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 47 | 61 | $13,928 | $6,520 | 46.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 68 | 108 | $7,186 | $3,963 | 55.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 49 | 49 | $6,887 | $3,154 | 45.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 67 | 74 | $5,508 | $2,899 | 52.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $5,339 | $2,675 | 50.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $1,170 | $474.50 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 367 | 482 | $45,790 | $28,458 | 62.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 92 | 141 | $63,450 | $16,247 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 199 | $25,074 | $16,048 | 64.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 301 | 395 | $35,550 | $13,702 | 38.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 189 | 219 | $24,090 | $13,678 | 56.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 124 | 145 | $16,530 | $11,204 | 67.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 244 | 1,594 | $44,632 | $7,379 | 16.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 32 | 35 | $6,930 | $4,180 | 60.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 47 | 47 | $5,922 | $3,456 | 58.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 51 | 71 | $4,189 | $2,739 | 65.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 78 | 82 | $5,412 | $2,670 | 49.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $4,536 | $2,614 | 57.6% |
About Dr. Dena Howell, MD
Dr. Dena Howell, MD is a Dermatology healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013970284.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dena Howell, MD has received a total of $10,483 in payments from pharmaceutical and medical device companies, with $1,071 received in 2024. These payments were reported across 408 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($10,097).
As a Medicare-enrolled provider, Howell has provided services to 7,610 Medicare beneficiaries, totaling 14,986 services with total Medicare billing of $537,389. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Mobile, AL
- Active Since 04/10/2006
- Last Updated 10/01/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1013970284
Products in Payments
- Humira (Biological) $852.45
- SKYRIZI (Biological) $830.66
- EUCRISA (Drug) $706.87
- COSENTYX (Biological) $598.48
- TREMFYA (Drug) $513.70
- RINVOQ (Biological) $474.18
- Puraply (Medical Supply) $426.81
- OPZELURA (Drug) $376.53
- TALTZ (Drug) $355.64
- DUPIXENT (Drug) $277.79
- DUPIXENT (Biological) $258.82
- Tolak (Drug) $243.66
- ATOPIC DERMATITIS - DISEASE (Drug) $243.59
- Winlevi (Drug) $231.72
- Otezla (Drug) $208.78
- ORACEA (Drug) $177.29
- VTAMA (Drug) $163.08
- ILUMYA (Biological) $162.73
- SOOLANTRA (Drug) $145.11
- STELARA (Biological) $132.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Mobile
Dr. John Vanloock, M.d, M.D
Dermatology — Payments: $1.4M
Dermatology $1.4M
Dr. Thomas Bender, Md, MD
Dermatology — Payments: $180,865
Dermatology $180,865
Kathryn Dempsey, M.d, M.D
Dermatology — Payments: $44,020
Dermatology $44,020
Dr. Ryan Ramagosa, M.d, M.D
Dermatology — Payments: $33,017
Dermatology $33,017
Virginia Reeder, M.d, M.D
Dermatology — Payments: $22,710
Dermatology $22,710
Aldo Trovato, Md, MD
Dermatology — Payments: $14,641
Dermatology $14,641